The distinction between receptor-positive (Normal like, Luminal A, Luminal B, and HER-2 positive) and receptor-negative (TNBC or basal like) subtypes of breast cancer has been made using gene expression profiling, in addition to histological subtypes (Kakudji et al., 2021). The gene discussed is ERBB2; the disease is breast cancer.